Surgery Partners, Inc. SGRY
$13.09
-$0.26-1.95%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 3.37B | 3.34B | 3.31B | 3.29B | 3.24B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.37B | 3.34B | 3.31B | 3.29B | 3.24B |
| Cost of Revenue | 2.61B | 2.58B | 2.54B | 2.50B | 2.47B |
| Gross Profit | 757.90M | 763.30M | 765.00M | 786.40M | 768.60M |
| SG&A Expenses | 121.70M | 121.50M | 118.20M | 130.50M | 137.30M |
| Depreciation & Amortization | 177.20M | 178.20M | 176.00M | 150.00M | 160.70M |
| Other Operating Expenses | -10.20M | -10.40M | -8.70M | -13.10M | -13.60M |
| Total Operating Expenses | 2.90B | 2.87B | 2.83B | 2.77B | 2.75B |
| Operating Income | 469.20M | 474.00M | 479.50M | 519.00M | 484.20M |
| Income Before Tax | 102.40M | 113.90M | 116.90M | 148.50M | 128.60M |
| Income Tax Expenses | 20.50M | 16.80M | 18.00M | 125.20M | 124.20M |
| Earnings from Continuing Operations | 81.90 | 97.10 | 98.90 | 23.30 | 4.40 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -170.50M | -173.20M | -176.80M | -194.70M | -184.80M |
| Net Income | -88.60M | -76.10M | -77.90M | -171.40M | -180.40M |
| EBIT | 469.20M | 474.00M | 479.50M | 519.00M | 484.20M |
| EBITDA | 646.40M | 652.20M | 655.50M | 669.00M | 644.90M |
| EPS Basic | -0.69 | -0.60 | -0.61 | -1.36 | -1.43 |
| Normalized Basic EPS | -0.31 | -0.30 | -0.26 | -0.13 | -0.10 |
| EPS Diluted | -0.70 | -0.60 | -0.62 | -1.36 | -1.43 |
| Normalized Diluted EPS | -0.31 | -0.30 | -0.26 | -0.13 | -0.10 |
| Average Basic Shares Outstanding | 512.43M | 510.58M | 508.82M | 507.00M | 505.96M |
| Average Diluted Shares Outstanding | 512.43M | 510.58M | 508.82M | 507.00M | 505.96M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |